Clinical Trial Update: Treatment of Deficient Subclass or Anti-polysaccharide Antibody Response [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on treatment for deficient subclass or anti-polysaccharide antibody response in individuals with IgG deficiency; the study status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Igg Deficiency

Snippet

Sponsor: Prothya Biosolutions | Conditions: IgG Deficiency, Infections | Phase 4 | Status: COMPLETED